Abstract
Hypoxia in tumor has close relationship with angiogenesis and tumor progression. Previously, we developed 2,2-dihydroxymethyl-3-[18F]fluoropropyl-2-nitroimidazole ([18F]DiFA) as a novel positron emission tomography (PET) probe for diagnosis of hypoxia. In this study, we elucidated whether the accumulation of [18F]DiFA in cells is dependent on the hypoxic state and revealed how [18F]DiFA accumulates in hypoxic cells in combination with imaging mass spectrometry (IMS). FaDu human head and neck cancer cells were treated with [18F]DiFA and then incubated under normoxia (21% O2) or hypoxia (1% O2) for 2 h. The cells were extracted using methanol, and the radioactivities of the precipitates (macromolecule fraction) and supernatants (low-molecular-weight fraction) were measured. FaDu-bearing mice were injected intravenously with [18F]DiFA and with pimonidazole 1 h later. The tumors were excised 2 h after the injection of [18F]DiFA. Autoradiography, IMS, and immunohistochemical (IHC) staining for pimonidazole were performed with serial tumor sections. In the in vitro study, the radioactivity of FaDu cells was significantly higher under hypoxia than that under normoxia (0.53 ± 0.02 vs. 0.27 ± 0.02 %dose/mg protein, p < 0.05). The radioa...Continue Reading
References
Nov 27, 1991·Biochemical Pharmacology·J L PrekegesK H Krohn
Dec 24, 1997·Analytical Chemistry·R M CaprioliJ Gile
May 9, 1998·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·S KomiyaA Inoue
Jul 29, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David S RiddickDavid J Waxman
Sep 1, 2005·Analytical Chemistry·Jason GobeyJay Corr
Mar 17, 2006·Rapid Communications in Mass Spectrometry : RCM·Seetharaman VaidyanathanRoyston Goodacre
Apr 4, 2008·Nature·Ralph Weissleder, Mikael J Pittet
Apr 19, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Esther G C TroostJohan Bussink
Jul 9, 2010·Nuclear Medicine and Biology·Romain BejotSally Hill
May 25, 2011·Nature Reviews. Cancer·William R Wilson, Michael P Hay
Nov 15, 2012·Nature Reviews. Clinical Oncology·Michael R HorsmanJens Overgaard
Jan 17, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Shozo OkamotoNagara Tamaki
Sep 24, 2015·Biochimica Et Biophysica Acta·Masayuki SugimotoYuji Kuge
Nov 19, 2015·International Journal of Clinical Oncology·Nagara Tamaki, Kenji Hirata
Nov 20, 2015·Scientific Reports·Yukiko MasakiYuji Kuge
Mar 25, 2016·PloS One·Masayuki SugimotoYuji Kuge
Sep 1, 2016·PloS One·Yukiko MasakiYuji Kuge
Jun 22, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Takuya ToyonagaTamaki Nagara
Jul 12, 2017·Annals of Nuclear Medicine·Yukiko MasakiYuji Kuge
Citations
Jan 30, 2019·Annals of Nuclear Medicine·Yoichi ShimizuMikako Ogawa
Jul 7, 2019·EJNMMI Research·Shiro WatanabeNagara Tamaki
Nov 2, 2018·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yoichi Shimizu
Jul 2, 2020·Organic & Biomolecular Chemistry·Jie GaoXianfeng Gu
Jul 28, 2019·Journal of Clinical Medicine·Kenji HirataNagara Tamaki
Jan 26, 2021·Nuclear Medicine and Biology·Tetsuro TagoHiroshi Tanaka
Jan 26, 2021·EJNMMI Research·Yoichi ShimizuYuji Nakamoto
Jan 11, 2021·Annals of Nuclear Medicine·Yoichi ShimizuMasahiro Ono
Sep 2, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Tomoki BoYuji Kuge
Oct 29, 2021·Journal of Medicinal Chemistry·Hiroyuki SuzukiYasushi Arano